메이저 바카라사이트 주사위 Bio&Pharma inks KRW 10 billion exclusive deal for Cell Bloom with Taiwan’s Chang Tai Energy

[by Ji, Yong Jun] 메이저 바카라사이트 주사위 Bio&Pharma announced on April 25 that it signed an exclusive supply agreement on April 18 with the Taiwanese conglomerate Chang Tai Energy (hereinafter referred to as Chang Tai) for the cosmeceutical skincare brand Cell Bloom, with the contract valued at around KRW 10 billion (approximately USD 6.9 million).

Chang 메이저 바카라사이트 주사위, a local partner, is a leading 메이저 바카라사이트 주사위wanese company that has established its growth foundation in the eco-friendly energy and resource recycling industries. In recent years, it has diversified its portfolio into sectors including renewable energy, biotechnology, healthcare, and cosmetics. The company is also accelerating its global expansion efforts, notably through the establishment of a U.S. subsidiary.

The recent entry of Cell Bloom into the Taiwanese market is garnering attention as a case of strategic synergy, combining Chang Tai’s strong local distribution network with 메이저 바카라사이트 주사위 Bio&Pharma’s product capabilities and brand value. Cell Bloom was recently granted official product approval by the Taiwanese Ministry of Health and Welfare (MHW), recognizing the product’s quality, safety, and innovation. Backed by a global response system grounded in a quality management framework that complies with international and local regulatory standards, 메이저 바카라사이트 주사위 Bio&Pharma plans to further accelerate its overseas expansion, with Taiwan serving as a key stepping stone.

Following the official approval of human-derived exosomes as cosmetic raw materials by the Taiwanese Ministry of Health and Welfare in March 2024, 메이저 바카라사이트 주사위 Bio&Pharma has responded quickly to emerging market trends by launching new human- and plant-derived stem cell exosome ampoules through its Taiwan-exclusive export line.

메이저 바카라사이트 주사위 Bio&Pharma, which recently became the largest shareholder of AreumMedics through the acquisition of newly issued shares, is actively pursuing global market expansion with its next-generation filler products. The company also plans to further strengthen its global presence in the cosmetics and skin booster sectors through continuous R&D investment, global collaboration, and actively responding to market diversification.

“This exclusive contract in Taiwan represents a strategic milestone in Cell Bloom’s global business expansion, going beyond mere distribution collaboration,” stated Cho Yong-joon, CEO of 메이저 바카라사이트 주사위 Bio&Pharma. “We will actively implement a global market strategy focused on Cell Bloom and high-functional skin booster products,” he added.